4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012395
EVP & Chief Financial Officer sold 1,634 shares at $9.53 ($15,576)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason EVP & Chief Financial Officer | 2026-02-24 | Sale 10b5-1 | −1,634 | $9.53 | $15,576 | 162,615 | D: show line 1 in the form |
| Open-market sales · 1,634 sh · avg $9.53 · $15,576 | |||||||
Loading xslF345X05/wk-form4_1772142937.xml…